[Skip to Navigation]
Invited Commentary
August 24, 2020

Private Equity, Women’s Health, and the Corporate Transformation of American Medicine

Author Affiliations
  • 1Division of Health Policy and Economics, Department of Population Health Sciences, Weill Cornell Medical College
JAMA Intern Med. 2020;180(11):1545-1546. doi:10.1001/jamainternmed.2020.3564

In this issue of JAMA Internal Medicine, Bruch and colleagues1 inform us that during the past decade, private equity firms have acquired or invested in large numbers of obstetrician-gynecologist medical groups. Most of these acquisitions and investments occurred during the past 3 years. Given the difficulty of identifying such acquisitions and investments, it is likely that their true number is even larger than Bruch and colleagues report, despite the labor-intensive methods the authors employed to identify them.

Add or change institution